April 16 (Reuters) - Drugmaker Apricus Biosciences Inc said on Monday the U.S. regulator directed it to develop a new formulation for its erectile dysfunction cream, Vitaros, which was rejected in February.



Latest News

CNBC: More than $85 billion in value wiped out from the popular 'FANG' tech stocks

CNBC: The consumer staples sector just did something it hasn't done since the financial crisis

WashingtonPost: Review: Twin Shadow once again flirts with ‘80s bombast

WashingtonPost: In ‘Handmaid’s Tale’ and ‘Homeland,’ two heroines judged by their devotion to motherhood

Daily Mail: AP Interview: Iran says if US exits deal, it likely...

Daily Mail: Lawyer whose work got entangled in Mueller probe leaves...

Daily Mail: 3 murdered Mexican film students caught in gang turf...

Daily Mail: US STOCKS-Wall St sunk by corporate cost warnings, bond...

Daily Mail: Macedonia: 8 million-year-old elephant-like remains found

Daily Mail: Former bus driver gets 4 years in crash that killed 6 kids

Daily Mail: Who is presenter Katy Hill?

Daily Mail: Amazon workers protest Bezos in Berlin

CBC: 'Idiotic' amount of paperwork for grants, say Yukon First Nation development corps.

BBC: Delay for Welsh compulsory salmon release law

WashingtonPost: Victim of Toronto van incident was a professional, volunteer

FOX: Wildlife photographer captures osprey carrying shark, carrying fish in 'one-in-a-trillion photograph'

USA Today: Oklahoma still looking for QB to replace Mayfield

USA Today: Prince Harry and Meghan Markle's royal wedding: What we know and what we don't know

Reuters: All 12 Wells Fargo director nominees elected, pay approved

Reuters: UPDATE 2-U.S. regulator fines Altaba $35 mln over 2014 Yahoo email hack

Reuters: UPDATE 2-FDA cracks down on sales of Juul tobacco products to minors

Times of Israel: Macron: France, US wish to work on ‘new nuclear deal’ with Iran

FOX: California chief vows review after stabbing by homeless man